TAMPA, Fla.--(BUSINESS WIRE)--June 14, 2006--Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI - News), announced that it has initiated the commercial launch of MD Turbo, which is now available by prescription. Accentia's commercial subsidiary, TEAMM Pharmaceuticals, began presenting MD Turbo to pharmacists on May 30th and will begin physician promotion on June 19th.
